From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA removes the brakes on Pfizer and Lilly's pain drug

from FierceBiotech

A once-halted pain candidate from partners Pfizer and Eli Lilly now has the green light to resume late-stage testing, as the FDA has lifted a clinical hold tied to some serious safety concerns for the whole class of drugs. The treatment, tanezumab, works by targeting nerve growth factor, a protein that regulates how the body processes pain. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063